ORIC Pharmaceuticals ORIC
$ 9.01
3.09%
Quarterly report 2024-Q3
added 11-12-2024
ORIC Pharmaceuticals Income Statement 2011-2024 | ORIC
Annual Income Statement ORIC Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
771 M | 201 M | 558 M | 889 M | - | - | - | - | - | - | - | - | - |
Shares |
51.5 M | 39.7 M | 38 M | 30.3 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
15 | 5.07 | 14.7 | 33.9 | - | - | - | - | - | - | - | - | - |
Net Income |
-101 M | -89.1 M | -78.7 M | -73.7 M | -26.9 M | -21.4 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-111 M | -91.8 M | -78.9 M | -74.2 M | -28.6 M | -22.4 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-110 M | -90.8 M | -78 M | -73.2 M | -27.5 M | -21.5 M | - | - | - | - | - | - | - |
Operating Expenses |
111 M | 91.8 M | 78.9 M | 74.2 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
25.6 M | 25.1 M | 22 M | 13.4 M | 5.72 M | 3.34 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement ORIC Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
70.5 M | 70.3 M | 67.3 M | 54.9 M | 57.4 M | 45.7 M | 45.1 M | 45.1 M | 39.6 M | 39.5 M | 39.4 M | 39.4 M | 39 M | 36.7 M | 36.7 M | 36.7 M | 30.3 M | 21.6 M | 1.99 M | 1.98 M | 1.95 M | 1.87 M | 1.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-34.6 M | -32 M | -25 M | - | -25.5 M | -22.9 M | -23.9 M | - | -24.8 M | -20.3 M | -23.2 M | - | -18.4 M | -21 M | -16.5 M | - | -25.5 M | -11 M | -8.87 M | - | -6.55 M | -5.96 M | -6.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-38.3 M | -36 M | -29 M | - | -28.7 M | -25 M | -25.7 M | - | -25.7 M | -20.7 M | -23.3 M | - | -18.5 M | -21.1 M | -16.6 M | - | -25.6 M | -11.1 M | -9.18 M | - | -7.1 M | -6.36 M | -6.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -28.7 M | - | - | - | -25.4 M | - | -25 M | -20.2 M | -23 M | - | -17.8 M | -20.6 M | -16.3 M | - | -24.9 M | -10.6 M | -8.93 M | - | -6.34 M | -5.87 M | -6.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
38.3 M | 36 M | 29 M | - | 28.7 M | 25 M | 25.7 M | - | 25.7 M | 20.7 M | 23.3 M | - | 18.5 M | 21.1 M | 16.6 M | - | 25.6 M | 11.1 M | 9.18 M | - | 7.1 M | 6.36 M | 6.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.12 M | 7.08 M | 7.03 M | - | 6.29 M | 6.2 M | 6.16 M | - | 5.97 M | 6.86 M | 6.43 M | - | 5.56 M | 5.54 M | 4.86 M | - | 3.8 M | 3.4 M | 1.92 M | - | 1.46 M | 1.32 M | 1.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency